We conducted this nationwide population-based cohort study of men with preexisting type 2 diabetes aiming to evaluate the association of exposure to GnRH agonists and PCa diagnosis per se with CVD risk and worsening hypertension. The gene discussed is GNRH1; the disease is Hypertension.